BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 11795656)

  • 1. Salt wasting in simple virilizing congenital adrenal hyperplasia.
    Frisch H; Battelino T; Schober E; Baumgartner-Parzer S; Nowotny P; Vierhapper H
    J Pediatr Endocrinol Metab; 2001; 14(9):1649-55. PubMed ID: 11795656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia.
    Dolzan V; Sólyom J; Fekete G; Kovács J; Rakosnikova V; Votava F; Lebl J; Pribilincova Z; Baumgartner-Parzer SM; Riedl S; Waldhauser F; Frisch H; Stopar-Obreza M; Krzisnik C; Battelino T
    Eur J Endocrinol; 2005 Jul; 153(1):99-106. PubMed ID: 15994751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal dexamethasone treatment in pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: effect on midgestational amniotic fluid steroid levels.
    Dörr HG; Sippell WG
    J Clin Endocrinol Metab; 1993 Jan; 76(1):117-20. PubMed ID: 8421074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM; Simm D; Beier C; Dörr HG
    Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rare CYP 21 mutation (p.E431K) induced deactivation of CYP 21A2 and resulted in congenital adrenal hyperplasia.
    Kawashima Y; Usui T; Fujimoto M; Miyahara N; Nishimura R; Hanaki K; Kanzaki S
    Endocr J; 2015; 62(1):101-6. PubMed ID: 25319875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
    Bonfig W; Schwarz HP
    Horm Res Paediatr; 2011; 75(4):264-8. PubMed ID: 21196707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational spectrum of congenital adrenal hyperplasia in Slovenian patients: a novel Ala15Thr mutation and Pro30Leu within a larger gene conversion associated with a severe form of the disease.
    Dolzan V; Stopar-Obreza M; Zerjav-Tansek M; Breskvar K; Krzisnik C; Battelino T
    Eur J Endocrinol; 2003 Aug; 149(2):137-44. PubMed ID: 12887291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
    Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK
    Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression and stimulation of mineralocorticoid hormones (MCH) in the simple virilizing form of congenital adrenal hyperplasia (CAH) evaluated by the quantitation in adrenal venous blood.
    Wajchenberg BL; Biglieri EG; Okada H; Malerbi DA; Achando SS; Kater CE
    J Steroid Biochem; 1983 Jul; 19(1B):655-61. PubMed ID: 6350722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic challenges in a patient with the simple virilizing (SV) form of congenital adrenal hyperplasia (CAH) due to the P30L/I172N genotype.
    Tankoska M; Anastasovska V; Krstevska-Konstantinova M; Naydenov M; Kocova M
    J Pediatr Endocrinol Metab; 2019 May; 32(5):543-547. PubMed ID: 31026224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
    Charmandari E; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone production despite absence or defectiveness of the CYP21 genes in two patients with salt-losing congenital adrenal hyperplasia caused by steroid 21-hydroxylase deficiency.
    Koppens PF; Hoogenboezem T; Drop SL; de Muinck-Keizer-Schrama SM; Degenhart HJ
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):815-22. PubMed ID: 10209571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
    Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density in girls with classical congenital adrenal hyperplasia due to CYP21 deficiency.
    Elnecave RH; Kopacek C; Rigatto M; Keller Brenner J; Sisson de Castro JA
    J Pediatr Endocrinol Metab; 2008 Dec; 21(12):1155-62. PubMed ID: 19189689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splicing mutation in CYP21 associated with delayed presentation of salt-wasting congenital adrenal hyperplasia.
    Kohn B; Day D; Alemzadeh R; Enerio D; Patel SV; Pelczar JV; Speiser PW
    Am J Med Genet; 1995 Jul; 57(3):450-4. PubMed ID: 7677150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenocortical adenoma associated with inadequately treated congenital adrenal hyperplasia.
    Kurtoğlu S; Atabek ME; Keskin M; Patiroglu TE
    J Pediatr Endocrinol Metab; 2003 Dec; 16(9):1311-4. PubMed ID: 14714757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia.
    Tschaidse L; Reisch N; Arlt W; Brac de la Perriere A; Linden Hirschberg A; Juul A; Mallappa A; Merke DP; Newell-Price JDC; Perry CG; Prete A; Rees DA; Stikkelbroeck NMML; Touraine PA; Coope H; Porter J; Ross RJM; Quinkler M
    Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36654495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siblings of 21-hydroxylase deficiency (non-salt-losing) with aldosterone hypersecretion.
    Morimoto I; Yamamoto S; Tateishi H; Ueda S; Toda Y; Zeki K; Watanabe K; Nakano Y; Kashimura M; Eto S
    Intern Med; 1992 May; 31(5):690-4. PubMed ID: 1324037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia.
    Charmandari E; Calis KA; Keil MF; Mohassel MR; Remaley A; Merke DP
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3197-200. PubMed ID: 12107224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperandrogenism in carriers of CYP21 mutations: the role of genotype.
    Admoni O; Israel S; Lavi I; Gur M; Tenenbaum-Rakover Y
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):645-51. PubMed ID: 16712666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.